A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation.
Saved in:
| Title: | A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation. |
|---|---|
| Authors: | Giorgino, Francesco1 (AUTHOR) francesco.giorgino@uniba.it, Taybani, Zoltán2 (AUTHOR), Cheng, Alice3 (AUTHOR), Tebaibia, Amar4 (AUTHOR), Anaforoglu, İnan5 (AUTHOR), Lauand, Felipe6 (AUTHOR), Servera, Soraly7 (AUTHOR), Li, Xuan1,7 (AUTHOR), Fonseca, Vivian8 (AUTHOR) |
| Source: | Diabetes Research & Clinical Practice. Nov2025, Vol. 229, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
